• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意大利 COVID-19 疫情的头 2 年:发病率、死亡率和卫生政策。

The first 2 years of COVID-19 in Italy: Incidence, lethality, and health policies.

机构信息

Department of Occupational and Environmental Medicine, Epidemiology and Hygiene, Italian National Workers' Compensation Authority (INAIL), Rome, Italy.

出版信息

Front Public Health. 2022 Nov 1;10:986743. doi: 10.3389/fpubh.2022.986743. eCollection 2022.

DOI:10.3389/fpubh.2022.986743
PMID:36388357
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9664068/
Abstract

BACKGROUND

The novel coronavirus disease 2019 (COVID-19) is an ongoing pandemic that was first recognized in China in December 2019. This paper aims to provide a detailed overview of the first 2 years of the pandemic in Italy.

DESIGN AND METHODS

Using the negative binomial distribution, the daily incidence of infections was estimated through the virus's lethality and the moving-averaged deaths. The lethality of the original strain (estimated through national sero-surveys) was adjusted daily for age of infections, hazard ratios of virus variants, and the cumulative distribution of vaccinated individuals.

RESULTS

From February 24, 2020, to February 28, 2022, there were 20,833,018 (20,728,924-20,937,375) cases distributed over five waves. The overall lethality rate was 0.73%, but daily it ranged from 2.78% (in the first wave) to 0.15% (in the last wave). The first two waves had the highest number of daily deaths (about 710) and the last wave showed the highest peak of daily infections (220,487). Restriction measures of population mobility strongly slowed the viral spread. During the 2nd year of the pandemic, vaccines prevented 10,000,000 infections and 115,000 deaths.

CONCLUSION

Almost 40% of COVID-19 infections have gone undetected and they were mostly concentrated in the first year of the pandemic. From the second year, a massive test campaign made it possible to detect more asymptomatic cases, especially among the youngest. Mobility restriction measures were an effective suppression strategy while distance learning and smart working were effective mitigation strategies. Despite the variants of concern, vaccines strongly reduced the pandemic impact on the healthcare system avoiding strong restriction measures.

摘要

背景

2019 年新型冠状病毒病(COVID-19)是一场正在进行的大流行,于 2019 年 12 月在中国首次被发现。本文旨在提供意大利大流行前 2 年的详细概述。

设计和方法

使用负二项分布,通过病毒的致死率和移动平均死亡人数来估计每日感染率。通过全国血清学调查,对原始毒株的致死率进行了每日调整,以适应感染年龄、病毒变异的危害比以及接种个体的累积分布。

结果

从 2020 年 2 月 24 日至 2022 年 2 月 28 日,共发生 20833018 例(20728924-20937375)病例,分为 5 波。总体致死率为 0.73%,但每日波动范围为 2.78%(第一波)至 0.15%(第五波)。前两波每日死亡人数最多(约 710 人),第五波每日感染人数最多(220487 人)。人口流动性限制措施大大减缓了病毒传播。在大流行的第二年,疫苗预防了 1000 万例感染和 11.5 万例死亡。

结论

COVID-19 感染中有近 40%未被发现,而且大部分集中在大流行的第一年。第二年,大规模的检测运动使得更多的无症状病例能够被发现,尤其是在最年轻的人群中。限制人口流动的措施是一种有效的抑制策略,而远程学习和远程办公则是有效的缓解策略。尽管出现了令人担忧的变异株,但疫苗大大减轻了大流行对医疗系统的影响,避免了采取强有力的限制措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0059/9664068/c7d8f1da3a85/fpubh-10-986743-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0059/9664068/a67a27815e7c/fpubh-10-986743-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0059/9664068/1602fb97e03d/fpubh-10-986743-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0059/9664068/c7d8f1da3a85/fpubh-10-986743-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0059/9664068/a67a27815e7c/fpubh-10-986743-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0059/9664068/1602fb97e03d/fpubh-10-986743-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0059/9664068/c7d8f1da3a85/fpubh-10-986743-g0003.jpg

相似文献

1
The first 2 years of COVID-19 in Italy: Incidence, lethality, and health policies.意大利 COVID-19 疫情的头 2 年:发病率、死亡率和卫生政策。
Front Public Health. 2022 Nov 1;10:986743. doi: 10.3389/fpubh.2022.986743. eCollection 2022.
2
The first year of COVID-19 in Italy: incidence, lethality, and health policies.意大利新冠疫情的第一年:发病率、致死率及卫生政策。
J Public Health Res. 2021 Oct 6;11(1):2201. doi: 10.4081/jphr.2021.2201.
3
First Wave of COVID-19 Pandemic in Italy: Data and Evidence.意大利的 COVID-19 大流行第一波:数据和证据。
Adv Exp Med Biol. 2021;1353:91-113. doi: 10.1007/978-3-030-85113-2_6.
4
Changes in severity of 2009 pandemic A/H1N1 influenza in England: a Bayesian evidence synthesis.英国 2009 年大流行性 A/H1N1 流感严重程度的变化:贝叶斯证据综合分析。
BMJ. 2011 Sep 8;343:d5408. doi: 10.1136/bmj.d5408.
5
[Surveillance of influenza pandemic (H1N1)2009 in Spain].[2009年西班牙甲型H1N1流感大流行监测]
Rev Esp Salud Publica. 2010 Sep-Oct;84(5):569-88. doi: 10.1590/s1135-57272010000500009.
6
[Technical guidelines for seasonal influenza vaccination in China (2022-2023)].《中国季节性流感疫苗接种技术指南(2022—2023年)》
Zhonghua Yu Fang Yi Xue Za Zhi. 2022 Oct 6;56(10):1356-1386. doi: 10.3760/cma.j.cn112150-20220825-00840.
7
Characterizing the epidemiology of the 2009 influenza A/H1N1 pandemic in Mexico.描述墨西哥 2009 年甲型 H1N1 流感大流行的流行病学特征。
PLoS Med. 2011 May;8(5):e1000436. doi: 10.1371/journal.pmed.1000436. Epub 2011 May 24.
8
Low adherence to influenza vaccination campaigns: is the H1N1 virus pandemic to be blamed?流感疫苗接种活动的低参与率:是否应该归咎于 H1N1 病毒大流行?
Ital J Pediatr. 2011 Nov 10;37:54. doi: 10.1186/1824-7288-37-54.
9
[Technical guidelines for seasonal influenza vaccination in China (2022-2023)].《中国季节性流感疫苗接种技术指南(2022—2023年)》
Zhonghua Liu Xing Bing Xue Za Zhi. 2022 Oct 10;43(10):1515-1544. doi: 10.3760/cma.j.cn112338-20220825-00734.
10
Critical policies disparity of the first and second waves of COVID-19 in the United Kingdom.英国第一波和第二波 COVID-19 期间的关键政策差距。
Int J Equity Health. 2022 Aug 22;21(1):115. doi: 10.1186/s12939-022-01723-3.

引用本文的文献

1
The Italian public health response during the pandemic emergency: from qualitative data to the "performance index" of care provided by Spoleto Hospital.意大利在大流行紧急情况下的公共卫生应对措施:从定性数据到斯波莱托医院提供的护理“绩效指数”
Front Public Health. 2025 Jun 16;13:1337375. doi: 10.3389/fpubh.2025.1337375. eCollection 2025.
2
Loneliness during the COVID-19 Pandemic in Patients with Burning Mouth Syndrome: A Multicentric Case-Control Italian Study.灼口综合征患者在新冠疫情期间的孤独感:一项意大利多中心病例对照研究
Depress Anxiety. 2023 Nov 8;2023:6666741. doi: 10.1155/2023/6666741. eCollection 2023.
3

本文引用的文献

1
Review of COVID-19 vaccine subtypes, efficacy and geographical distributions.新型冠状病毒疫苗亚型、疗效和地理分布综述。
Postgrad Med J. 2022 May 1;98(1159):389-394. doi: 10.1136/postgradmedj-2021-140654.
2
Clinical Characteristics, Transmissibility, Pathogenicity, Susceptible Populations, and Re-infectivity of Prominent COVID-19 Variants.新冠病毒主要变异株的临床特征、传播性、致病性、易感人群及再感染性
Aging Dis. 2022 Apr 1;13(2):402-422. doi: 10.14336/AD.2021.1210. eCollection 2022 Apr.
3
Evaluating COVID-19 Vaccine Willingness and Hesitancy among Parents of Children Aged 5-11 Years with Chronic Conditions in Italy.
Exposure to obinutuzumab does not affect outcomes of SARS-CoV-2 infection in vaccinated patients with newly diagnosed advanced-stage follicular lymphoma.
对于新诊断的晚期滤泡性淋巴瘤的接种疫苗患者,暴露于奥妥珠单抗并不影响其感染SARS-CoV-2的结果。
Br J Haematol. 2024 Dec;205(6):2219-2227. doi: 10.1111/bjh.19661. Epub 2024 Jul 22.
4
Surfing the Waves of SARS-CoV-2: Analysis of Viral Genome Variants Using an NGS Survey in Verona, Italy.追踪新冠病毒的变异浪潮:利用下一代测序技术对意大利维罗纳地区的病毒基因组变异进行分析
Microorganisms. 2024 Apr 24;12(5):846. doi: 10.3390/microorganisms12050846.
5
The First Two Years of COVID-19 Hospitalization Characteristics and Costs: Results from the National Discharge Registry.新冠疫情住院治疗的头两年:特征与费用——来自国家出院登记处的结果
Healthcare (Basel). 2024 May 7;12(10):958. doi: 10.3390/healthcare12100958.
6
Older adults' experiences of wellbeing during the COVID-19 pandemic: a comparative qualitative study in Italy and Switzerland.老年人在新冠疫情期间的幸福感体验:意大利和瑞士的一项比较性定性研究
Front Sociol. 2024 May 1;9:1243760. doi: 10.3389/fsoc.2024.1243760. eCollection 2024.
7
Which variables and determinants influence online food delivery consumption among workers and students? Results from the DELIvery Choice In OUr Society (DELICIOUS) cross-sectional study.哪些变量和决定因素影响了工人和学生群体对在线食品配送的消费?来自我们社会的交付选择(DELIVERY CHOICE IN OUR SOCIETY,简称 DELICIOUS)的横断面研究结果。
Front Public Health. 2024 Jan 8;11:1326628. doi: 10.3389/fpubh.2023.1326628. eCollection 2023.
8
Persistence of circulating CD169+monocytes and HLA-DR downregulation underline the immune response impairment in PASC individuals: the potential contribution of different COVID-19 pandemic waves.循环CD169+单核细胞的持续存在和HLA-DR下调突显了新冠后综合征(PASC)个体的免疫反应受损:不同新冠疫情浪潮的潜在影响。
Curr Res Microb Sci. 2023 Dec 12;6:100215. doi: 10.1016/j.crmicr.2023.100215. eCollection 2024.
9
Estimating SARS-CoV-2 infections and associated changes in COVID-19 severity and fatality.估算 SARS-CoV-2 感染以及 COVID-19 严重程度和病死率的相关变化。
Influenza Other Respir Viruses. 2023 Aug 16;17(8):e13181. doi: 10.1111/irv.13181. eCollection 2023 Aug.
10
Post-COVID Symptoms in Occupational Cohorts: Effects on Health and Work Ability.新冠后症状在职业人群中的表现:对健康和工作能力的影响。
Int J Environ Res Public Health. 2023 Apr 25;20(9):5638. doi: 10.3390/ijerph20095638.
评估意大利5至11岁慢性病儿童家长对新冠疫苗的接种意愿和犹豫态度。
Vaccines (Basel). 2022 Mar 4;10(3):396. doi: 10.3390/vaccines10030396.
4
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.比较分析英国住院和死亡风险与 SARS-CoV-2 奥密克戎(B.1.1.529)和德尔塔(B.1.617.2)变异株的关系:一项队列研究。
Lancet. 2022 Apr 2;399(10332):1303-1312. doi: 10.1016/S0140-6736(22)00462-7. Epub 2022 Mar 16.
5
Primary COVID-19 vaccine cycle and booster doses efficacy: analysis of Italian nationwide vaccination campaign.主要 COVID-19 疫苗接种周期和加强剂量的效果:意大利全国疫苗接种运动分析。
Eur J Public Health. 2022 Apr 1;32(2):328-330. doi: 10.1093/eurpub/ckab220.
6
COVID-19 vaccine strategies must focus on severe disease and global equity.新冠病毒疫苗策略必须聚焦于重症疾病和全球公平性。
Lancet. 2022 Jan 22;399(10322):406-410. doi: 10.1016/S0140-6736(21)02835-X. Epub 2021 Dec 16.
7
The Disease Severity and Clinical Outcomes of the SARS-CoV-2 Variants of Concern.关注的 SARS-CoV-2 变异株的疾病严重程度和临床结局。
Front Public Health. 2021 Nov 30;9:775224. doi: 10.3389/fpubh.2021.775224. eCollection 2021.
8
SARS-CoV-2 transmission across age groups in France and implications for control.法国各年龄段人群中 SARS-CoV-2 的传播情况及其对控制的影响。
Nat Commun. 2021 Nov 25;12(1):6895. doi: 10.1038/s41467-021-27163-1.
9
Covid-19 vaccines and variants of concern: A review.Covid-19 疫苗和关注变种:综述。
Rev Med Virol. 2022 Jul;32(4):e2313. doi: 10.1002/rmv.2313. Epub 2021 Nov 9.
10
Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study.辉瑞-BioNTech 信使核糖核酸 COVID-19 疫苗在美国大型综合卫生系统中的 6 个月有效性:一项回顾性队列研究。
Lancet. 2021 Oct 16;398(10309):1407-1416. doi: 10.1016/S0140-6736(21)02183-8. Epub 2021 Oct 4.